Group 1 - The animal vaccine sector experienced a decline of 0.72% as of the market close on August 22, ranking among the top declines in concept sectors [1] - Within the animal vaccine sector, companies such as Shenlian Biological, Weilan Biological, and Xianfeng Holdings saw significant declines, while Kexing Pharmaceutical, Haizheng Pharmaceutical, and Guoyao Modern recorded increases of 2.06%, 0.44%, and 0.09% respectively [1] - The overall market saw a net outflow of 0.68 billion yuan from the animal vaccine sector, with 11 stocks experiencing net outflows, and 6 stocks seeing outflows exceeding 10 million yuan [2] Group 2 - The top net outflow in the animal vaccine sector was from Kanghua Biological, with a net outflow of 30.50 million yuan, followed by Shenlian Biological, Dabeinong, and Jinhai Biological with outflows of 27.38 million yuan, 24.27 million yuan, and 23.53 million yuan respectively [2] - Conversely, the stocks with the highest net inflows included Haizheng Pharmaceutical, Kexing Pharmaceutical, and Luoniushan, with net inflows of 27.34 million yuan, 16.70 million yuan, and 10.38 million yuan respectively [3] - The trading activity in the animal vaccine sector showed that Kanghua Biological had a turnover rate of 3.52% and a decline of 1.70%, while Kexing Pharmaceutical had a turnover rate of 3.12% and an increase of 2.06% [3]

证券之星消息，8月22日动物保健板块较上一交易日下跌0.76%，永顺生物领跌。当日上证指数报收于 3825.76，上涨1.45%。深证成指报收于12166.06，上涨2.07%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 839729 | 永顺生物 | 11.18 | -4.36% | 9.16万 | 1.02亿 | | 871970 | 大禹生物 | 10.13 | -2.78% | 3.27万 | 3349.38万 | | 688098 | 申联生物 | 12.74 | -2.00% | 31.76万 | 4.12亿 | | 002141 | 贤丰控股 | 4.39 | -1.79% | 1 82.44万 | 3.67亿 | | 002688 | 金河生物 | 7.27 | -1.36% | 40.45万 | 2.93亿 | | 002868 | *ST绿康 | 28.45 | -1.22% | 9561.0 | 2728.17万 | | 838275 | ...

Group 1 - Jinhe Biological plans to establish a wholly-owned subsidiary with an investment of 10 million yuan to expand into the pet business, focusing on pet food and supplies, food additives, and medical research [1] - CNOOC Development intends to sell its cold energy business and assets to a related party for a total of 371 million yuan [1] - Shentong Express reported a revenue of 4.287 billion yuan in July, a year-on-year increase of 9.95% [2] Group 2 - Haosai received a warning letter from the Beijing Securities Regulatory Bureau due to suspected bribery involving its controlling shareholder [4] - Zhenyang Development is planning a major asset restructuring, leading to a temporary suspension of its stock [5] - Chitianhua's subsidiary will undergo a planned maintenance shutdown for 35 days, which will not affect the annual production targets [7] Group 3 - Aikang Pharmaceutical reported a net loss of 139 million yuan in the first half of the year, despite a revenue increase of 10.26% [8] - Zhaojin Gold achieved a net profit of 446.946 million yuan in the first half of the year, reversing a loss from the previous year [9] - CNOOC Development reported a net profit of 1.83 billion yuan in the first half of the year, a year-on-year increase of 13.15% [10] Group 4 - Hanchuan Intelligent reported a net profit of 22.935 million yuan in the first half of the year, compared to a loss in the same period last year [11] - Songyuan Safety's net profit increased by 30.85% year-on-year, with a revenue of 1.148 billion yuan [12] - Hengdian Film reported a net profit of 202 million yuan, a year-on-year increase of 128.61% [13] Group 5 - Ruoyu Chen's net profit increased by 85.6% year-on-year, with a revenue of 1.319 billion yuan [14] - Ruida Futures reported a net profit of 228 million yuan, a year-on-year increase of 66.49% [16] - Yangjie Technology's net profit increased by 41.55% year-on-year, with a revenue of 3.455 billion yuan [17] Group 6 - Yahua Group reported a net profit of 136 million yuan, a year-on-year increase of 32.87% [19] - Zhenyou Technology reported a net loss of 47.594 million yuan in the first half of the year [20] - Xinghui Co., Ltd. announced a share transfer agreement involving 6.99% of its shares [21] Group 7 - Shaanxi Natural Gas plans to transfer 13% of its shares through an agreement [23] - Zhenyou Technology received government subsidies totaling 6.0487 million yuan, accounting for 22.05% of its net profit [25] - Kema Technology plans to reduce its shareholding by up to 1.72% through a strategic employee placement plan [26]

证券之星消息，8月20日动物保健板块较上一交易日上涨0.27%，贤丰控股领涨。当日上证指数报收于 3766.21，上涨1.04%。深证成指报收于11926.74，上涨0.89%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 002141 | 后丰控股 | 4.66 | 9.91% | 128.85万 | | 5.73亿 | | 688526 | 科前生物 | 17.75 | 1.02% | 3.69万 | | 6491.03万 | | 838275 | 驱动力 | 10.24 | 0.69% | 2.68万 | | 2725.11万 | | 603566 | 普莱柯 | 15.30 | 0.39% | 5.28万 | | 8055.89万 | | 600195 | 中牧股份 | 7.70 | 0.39% | 10.24万 | | 7851.28万 | | 871970 | 大禹生物 | 10.27 | 0.39% | 3.79万 | | 3888. ...

中国经济网北京8月20日讯金河生物（002688）(002688.SZ)昨日晚间发布公告称，公司于2025年8月19 日收到内蒙古金河控股有限公司(以下简称"金河控股")及一致行动人出具的《简式权益变动报告书》， 金河控股于2025年8月11日至2025年8月19日通过大宗交易和集中竞价交易方式减持公司股份15,504,500 股，减持后，金河控股及其一致行动人合计持有公司股份263,239,552股，占公司总股本比例35.0000% (占比指占剔除公司回购专用账户中的股份数量后的总股本的比例)，股份变动触及5%的整数倍。 2025年8月11日，金河控股通过大宗交易方式减持5,065,000股，减持比例0.6735%，减持均价为6.98元/ 股；2025年8月18日，金河控股通过大宗交易方式减持9,977,100股，减持比例1.3265%，减持均价为6.72 元/股；2025年8月19日，金河控股通过集中竞价方式减持462,400股，减持比例0.0615%，减持均价为 7.51元/股。 经计算，2025年8月11日至2025年8月19日，金河控股减持总金额为105,872,436元。 | 股东名称 | 减持方 ...

Core Viewpoint - The company, Jinhe Biological, has announced the establishment of a wholly-owned subsidiary, Jinhe Aichongyi (Shanghai) Biotechnology Co., Ltd., with an investment of 10 million yuan to expand its pet business and enhance market competitiveness in the pet sector [1] Group 1 - The investment amount is 10 million yuan [1] - The new subsidiary is located in Shanghai [1] - The pet sector is a significant part of the company's strategic planning [1] Group 2 - The investment aims to further develop the company's pet business [1] - The initiative is expected to promote the development of the large animal protection industry [1]

Group 1 - The company, Jinhe Biological, announced the establishment of a wholly-owned subsidiary, Jinhe Aichongyi (Shanghai) Biotechnology Co., Ltd., with a registered capital of 10 million yuan [1] - The investment of 10 million yuan is aimed at expanding the company's pet business, which is a crucial part of its strategic planning [1] - The establishment of the subsidiary is intended to enhance the company's market competitiveness in the pet sector and promote the development of the large animal protection industry [1]

2025年1至6月份，金河生物的营业收入构成为：兽用化学药品占比61.83%，农产品加工业占比 19.76%，兽用生物制品占比11.12%，环保业务占比4.97%，其他占比2.15%。 （文章来源：每日经济新闻） 金河生物（SZ 002688，收盘价：7.49元）8月19日晚间发布公告称，金河生物科技股份有限公司2025年 8月18日召开第六届董事会第二十九次会议，以9票同意，0票反对，0票弃权审议通过了《关于对外投资 设立全资子公司的议案》，同意公司以自有资金投资1000万元于上海市设立全资子公司金河艾宠易（上 海）生物技术有限公司。 ...

证券代码：002688 证券简称：金河生物 公告编号：2025-077 金河生物科技股份有限公司 第六届监事会第二十四次会议决议公告 本公司及监事会全体人员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 金河生物科技股份有限公司（以下简称"公司"）第六届监事会第二十四次 会议于 2025 年 8 月 11 日以专人送达、传真等方式发出通知，并于 2025 年 8 月 18 日以通讯方式召开，会议由监事会主席张千岁先生主持，应到监事 3 人，实 到监事 3 人，本次监事会出席会议监事人数符合法律法规，会议合法有效。会议 召开符合《中华人民共和国公司法》等法律、法规和《公司章程》的规定。与会 监事审议通过了以下议案： 一、以 3 票同意，0 票反对，0 票弃权审议通过了《关于对外投资设立全资 子公司的议案》。 具体内容详见公司同日在《证券时报》《中国证券报》《上海证券报》《证 券日报》和巨潮资讯网（http://www.cninfo.com.cn）披露的《关于对外投资设 立全资子公司的公告》。 二、以 3 票同意，0 票反对，0 票弃权审议通过了《关于调整 2024 年股票 ...

证券代码：002688 证券简称：金河生物 公告编号：2025-076 金河生物科技股份有限公司 第六届董事会第二十九次会议决议公告 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 金河生物科技股份有限公司（以下简称"公司"）第六届董事会第二十九次 会议于 2025 年 8 月 11 日以电子邮件方式发出通知，并于 2025 年 8 月 18 日以通 讯方式召开，会议由董事长王东晓先生主持，应到董事 9 人，实到董事 9 人，本 次董事会出席会议董事人数符合法律法规，会议合法有效。会议召开符合《中华 人民共和国公司法》等法律、法规和《公司章程》的规定。与会董事以通讯表决 的方式审议通过了以下议案： 一、以 9 票同意，0 票反对，0 票弃权审议通过了《关于对外投资设立全资 子公司的议案》。 鉴于公司 2024 年年度权益分派方案已于 2025 年 6 月 6 日实施完毕，董事会 同意根据《金河生物科技股份有限公司 2024 年股票期权激励计划》的规定，对 行权价格进行相应的调整。调整后的股票期权行权价格由 2.94 元/份调整为 2.84 元/份。 ...